Anand Sistla

687 total citations
8 papers, 472 citations indexed

About

Anand Sistla is a scholar working on Oncology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Anand Sistla has authored 8 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pharmaceutical Science. Recurrent topics in Anand Sistla's work include Cancer Treatment and Pharmacology (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers) and Crystallization and Solubility Studies (2 papers). Anand Sistla is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers) and Crystallization and Solubility Studies (2 papers). Anand Sistla collaborates with scholars based in United States. Anand Sistla's co-authors include Jean Cui, Todd Miller, Yong Zhou, Hui Chen, Flora Tang, Chris Liang, James Cheng‐Chung Wei, Tony C. Luu, Cho Tang and Xueyan Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Drug Delivery.

In The Last Decade

Anand Sistla

8 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anand Sistla United States 6 223 162 126 104 63 8 472
Tony C. Luu United States 5 218 1.0× 157 1.0× 111 0.9× 94 0.9× 69 1.1× 5 470
Asaad Nematalla United States 7 269 1.2× 240 1.5× 123 1.0× 101 1.0× 56 0.9× 13 547
Todd Miller United States 4 267 1.2× 179 1.1× 139 1.1× 107 1.0× 64 1.0× 6 547
Quincy Chu United States 10 284 1.3× 122 0.8× 187 1.5× 131 1.3× 96 1.5× 19 478
Andrew McGown United Kingdom 11 325 1.5× 107 0.7× 228 1.8× 37 0.4× 111 1.8× 28 661
Stephen M. Courtney United Kingdom 12 346 1.6× 215 1.3× 95 0.8× 109 1.0× 20 0.3× 15 572
Eiji Nishiwaki Japan 14 395 1.8× 195 1.2× 190 1.5× 93 0.9× 71 1.1× 17 787
Joerg Berghausen Switzerland 6 455 2.0× 83 0.5× 162 1.3× 51 0.5× 51 0.8× 10 659
André Richters Germany 17 480 2.2× 212 1.3× 144 1.1× 44 0.4× 111 1.8× 24 776
Mauro Angiolini Italy 10 387 1.7× 247 1.5× 139 1.1× 45 0.4× 18 0.3× 14 587

Countries citing papers authored by Anand Sistla

Since Specialization
Citations

This map shows the geographic impact of Anand Sistla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand Sistla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand Sistla more than expected).

Fields of papers citing papers by Anand Sistla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand Sistla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand Sistla. The network helps show where Anand Sistla may publish in the future.

Co-authorship network of co-authors of Anand Sistla

This figure shows the co-authorship network connecting the top 25 collaborators of Anand Sistla. A scholar is included among the top collaborators of Anand Sistla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand Sistla. Anand Sistla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sistla, Anand, et al.. (2010). Medium-throughput hydrate screening using the Crystal 16. Pharmaceutical Development and Technology. 16(2). 102–109. 5 indexed citations
2.
Sistla, Anand, et al.. (2009). Pharmacokinetics and tissue distribution of liposomal etoposide in rats. Drug Delivery. 16(8). 423–429. 7 indexed citations
3.
Sistla, Anand, et al.. (2008). Development of an intravenous formulation of SU010382 (prodrug of SU5416, an anti-angiogenesis agent).. PubMed. 62(3). 200–10. 6 indexed citations
4.
Sistla, Anand, et al.. (2006). High-performance liquid chromatographic method for determination of reversible isomers of SU5416. Journal of Chromatography A. 1110(1-2). 73–80. 8 indexed citations
5.
Sistla, Anand, et al.. (2006). The Influence of Molecular Recognition on the Hydration of AG-013958 in the Solid State. Molecular Crystals and Liquid Crystals. 456(1). 117–131. 1 indexed citations
6.
Sistla, Anand & Narmada Shenoy. (2005). Reversible Z-E Isomerism and Pharmaceutical Implications for SU5416. Drug Development and Industrial Pharmacy. 31(10). 1001–1007. 9 indexed citations
7.
Sistla, Anand, et al.. (2004). Powder‐in‐Bottle Formulation of SU011248. Enabling Rapid Progression into Human Clinical Trials. Drug Development and Industrial Pharmacy. 30(1). 19–25. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026